Duearity AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DEAR.ST research report →
Companywww.duearity.com
Duearity AB (publ), a medical technology company, engages in the development of Tinearity, a tinnitus aid. The company's Tinearity contains a small sound element that generates white noise directly into the ear via the skull. It also develops Tinearity AI, an artificial intelligence-based solution that would help people suffering from or bothered by tinnitus to take command and master their symptoms.
- CEO
- Fredrik Westman
- IPO
- 2021
- Employees
- 2
- HQ
- Malmö, SE
Price Chart
Valuation
- Market Cap
- $3.08M
- P/E
- -0.01
- P/S
- 1.87
- P/B
- -0.12
- EV/EBITDA
- -0.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -252.60%
- Op Margin
- -1557.62%
- Net Margin
- -1583.43%
- ROE
- -1424.53%
- ROIC
- -314.34%
Growth & Income
- Revenue
- $1.65M · 0.00%
- Net Income
- $-26,190,000 · -35.60%
- EPS
- $-0.40 · 68.50%
- Op Income
- $-25,763,000
- FCF YoY
- -22.77%
Performance & Tape
- 52W High
- $2.29
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.10
- Beta
- 1.80
- Avg Volume
- 0
Get TickerSpark's AI analysis on DEAR.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DEAR.ST Coverage
We haven't published any research on DEAR.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DEAR.ST Report →